Neuroendocrine Cancer | Tumor

CURE’s neuroendocrine cancer page features the latest cancer news and updates on neuroendocrine cancer Through articles, videos, podcasts, and more, CURE brings readers the insights of experts, cancer survivors, patients, and advocates to ensure everyone is up to date in neuroendocrine cancer.

During the Pre-Cancer Days, My Intuition Pushed Me in the Right Direction

April 27th 2022

Before being diagnosed with neuroendocrine cancer, I started to live a healthier life and took notice of some concerning symptoms.

Potential FDA Cancer Drug Approvals on the Horizon This Spring

March 24th 2022

The Food and Drug Administration plans on reviewing multiple new cancer therapies this spring.

3 Stages of Coping With Cancer: There Are Better Days Ahead

March 3rd 2022

When I was first diagnosed with a stage 4 neuroendocrine tumor in my small intestine, I went through three stages of coping with my cancer: anger, planning and living life.

Trial Underway to Assess Efficacy of Novel Radiopharmaceutical Drug in Neuroendocrine Tumors

January 5th 2022

The phase 3 COMPOSE trial will look at the efficacy of using 177lu-edotreotide — a novel radiopharmaceutical that is designed to limit radiation exposure to normal tissue — in patients with later stage neuroendocrine tumors.

Patients With Neuroendocrine Tumors May ‘Achieve the Cure’ With Liver-Directed Therapies

December 13th 2021

For patients with neuroendocrine tumors that have spread, curating a liver-directed approach may make their treatment process less risky and less invasive, according to an expert.

The Importance of Neuroendocrine Tumor Imaging

December 1st 2021

Catching tumors through imaging at an early stage can help guide treatment decisions and may improve a patient’s quality of life — which is why it’s important for patients to stay educated on their options.

The Devastating Experience of Finding Out Your Child Has a Rare Cancer: Part 2

September 24th 2021

It is vital to find support when your child has cancer. In this two-part episode of the “CURE® Talks Cancer” podcast, a family shares how they were able to remain strong as their 9-year-old was treated for neuroendocrine cancer.

The Devastating Experience of Finding Out Your Child Has a Rare Cancer: Part 1

September 23rd 2021

Where do you turn when your child is diagnosed with a rare cancer? In this two-part episode of the “CURE® Talks Cancer” podcast, a family shares the harrowing experience of learning their nine-year-old had neuroendocrine cancer.

Inlyta-Synthetic Hormone Combo Fails to Significantly Improve Survival Outcome in Pancreatic Neuroendocrine Tumors

January 20th 2021

The combination of Inlyta (axitinib) and the synthetic hormone octreotide acetate failed to significantly improve progression-free survival, compared to placebo with the synthetic hormone. However, the results indicated the Inlyta-based combination did improve disease response in patients versus the placebo-based combination.

Appendix Cancer: An Elusive Diagnosis

August 26th 2020

Often uncovered by accident, appendiceal cancers trigger few symptoms until they’re advanced and can be difficult to detect and treat.

'Slumdog Millionaire' Actor Dies 2 Years After Cancer Diagnosis, LUNGevity Launches Fund to Provide Financial Assistance to Patients With Lung Cancer During COVID-19, and More

May 1st 2020

From a renowned actor passing away after a rare neuroendocrine cancer diagnosis and years of treatment to LUNGevity announcing a new fund for patients with lung cancer in need of financial assistance during the COVID-19 pandemic, here’s what’s happening in the cancer space this week.

Cancer Survivors Are Equipped to Handle Quarantine

April 14th 2020

COVID-19 has forced many people into a “new normal” that they aren’t familiar with and may not be equipped to handle. But cancer survivors are more prepared than most to handle the ramifications of the pandemic.

Patients With High-Grade Neuroendocrine Tumors Show Response After Opdivo/Yervoy Treatment

September 27th 2019

Treatment with Opdivo (nivolumab) plus Yervoy (ipilimumab) led to a 44% response rate in patients with high-grade neuroendocrine tumors, according to phase 2 study findings.

Friday Frontline: Cancer Updates, Research and Education on August 23, 2019

August 23rd 2019

From celebrity news to a new partnership aimed to help patients and their caregivers, here’s what is making headlines in the cancer space this week.

Dedicated to Oncology

June 15th 2019

This essay was written by Tracey M. Hopkins nominating registered nurse Rubirosa Ison, St. Joseph’s Hospital-North, Lutz, Florida, for CURE®’s 2019 Extraordinary Healer® Award.

Poker Face or Cancer Card?

October 12th 2017

Before I was diagnosed, I had my share of illnesses, but none that slowed me down like cancer could.

Cancer Isn't All About Me

October 4th 2017

Since my diagnosis of incurable and metastatic neuroendocrine cancer in 2010, it's really all been about me.